Takuya Murata

Dr. Takuya Murata


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Neuroscience Letters
Verified
Journal Article
Closed access
TMTakuya Murata
Takuya Murata
NTNaoya Tochio
Naoya Tochio
NUNaoko Utsunomiya-Tate
Naoko Utsunomiya-Tate

13 January 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
GIGenta Ito
Genta Ito
TMTakuya Murata
Takuya Murata
NINoriko Isoo
Noriko Isoo
THToshihiro Hayashi
Toshihiro Hayashi
NUNaoko Utsunomiya-Tate
Naoko Utsunomiya-Tate
The aggregation of tau protein is a central pathological event in Alzheimer’s disease, and this pathology is hypothesized to spread via a prion-like mechanism driven by tau “seeds”. While aggregated tau from Alzheimer’s disease brains is known to contain age-related d-isomerized aspartic acid (d-Asp) residues, it remains unknown how this modification affects the seeding activity that drives disease propagation. Here, we investigated the impact of site-specific d-isomerization within R2 and R3 tau repeat-domain peptides, which form the core of tau fibrils. We demonstrate that the stereochemical integrity of these peptides is critical for their seeding function. d-isomerization at Asp314 within the R3 peptide seed severely impaired its ability to template the fibrillization of full-length tau in vitro. This finding was validated in a cellular model, where R3 seeds containing d-Asp314 were significantly less potent at inducing the formation of phosphorylated tau aggregates compared to wild-type seeds. Our results establish that Asp d-isomerization within tau seeds acts as a potent attenuator of their pathological seeding activity, suggesting this spontaneous modification may intrinsically modulate the progression of Alzheimer’s disease.